The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019
Hallucinogens and Their Therapeutic Use: A Literature Review
BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019
Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.
Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. | Pharmacology & therapeutics | 27 August 2019
MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.
Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019
Classical psychedelics for the treatment of depression and anxiety: A systematic review.
Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019
Esketamine for treatment resistant depression.
Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., ... & Demas, M. L. | Expert Review of Neurotherapeutics | 16 July 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.
Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants
Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
Kuypers, K. P., Ng, L., Erritzoe, D., Knudsen, G. M., Nichols, C. D., Nichols, D. E., ... & Nutt, D. | Journal of Psychopharmacology | 14 July 2019
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. | Journal of Psychopharmacology | 11 July 2019
Psychedelic microdosing benefits and challenges: an empirical codebook.
Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., ... & Hapke, E. | 10 July 2019 | Harm reduction journal
Harnessing Neuroimaging to Enhance Our Understanding of the Effects of Ketamine in Depression.
Jaworska, N., & Phillips, J. L. | Cognitive neuroscience and neuroimaging | 1 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019
Psychedelic crossings: American mental health and LSD in the 1970s.
Richert, L., & Dyck, E. | Medical Humanities | 23 June 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Hashimoto, K. | Psychiatry and Clinical Neurosciences | 19 June 2019
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018
Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants.
Derntl, B., Hornung, J., Sen, Z. D., Colic, L., Li, M., & Walter, M. | Frontiers in neuroscience | 18 June 2019
Replication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019
Collective self-experimentation in patient-led research: How online health communities foster innovation
Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.
Almeida, R. N., Galvão, A. C. D. M., Da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., ... & Galvão-Coelho, N. | Frontiers in psychology | 4 June 2019
Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers
Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019